SCHEMBL5930

SCHEMBL5930

CC(C)N(C(C)C)P(OC(C)(C)C)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15883181 0.85
SCHEMBL2479770 0.77
SCHEMBL24189099 0.74
SCHEMBL19160447 0.74
SCHEMBL1763990 0.72
SCHEMBL1603737 0.72
SCHEMBL12793092 0.72
SCHEMBL385951 0.71
SCHEMBL314815 0.67
SCHEMBL4445856 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 946 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258506-B2 Films comprising bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2025-03-25 US claimed
US-20240209257-A1 FILMS COMPRISING BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES SHOEI CHEMICAL INC. (JP) 2024-06-27 US claimed
US-11926776-B2 Films comprising bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2024-03-12 US claimed
EP-4314193-A1 STABLE AIGS FILMS Shoei Chemical Inc. (JP) 2024-02-07 EP claimed
CN-117396581-A Stable AIGS film 纳米系统公司 2024-01-12 CN claimed
EP-4267691-A1 FILMS COMPRISING BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES Nanosys, Inc. (US) 2023-11-01 EP claimed
CN-116981754-A Film comprising bright silver-based quaternary nanostructures 纳米系统公司 2023-10-31 CN claimed
CN-116745025-A membrane for water filtration 水通道蛋白有限公司 2023-09-12 CN claimed
US-20230002672-A1 FILMS COMPRISING BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES NANOSYS, INC. (US) 2023-01-05 US claimed
WO-2022212517-A1 STABLE AIGS FILMS NANOSYS, INC. (US) 2022-10-06 WO claimed
EP-2088865-B1 GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS JINA PHARMACEUTICALS INC (US) 2015-10-21 EP claimed
CN-104803911-A Pleuromutilin compounds, drug composition, synthesis method and uses thereof SHANGHAI INST MATERIA MEDICA 2015-07-29 CN claimed
EP-2069339-B1 SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES WOCKHARDT RESEARCH CENTER (IN) 2011-05-18 EP claimed
US-20100151002-A1 Guggulphospholipid Methods and Compositions JINA PHARMACEUTICALS, INC. (US) 2010-06-17 US claimed
US-20100120721-A1 SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES WOCKHARDT RESEARCH CENTRE (IN) 2010-05-13 US claimed
US-7649018-B2 Mono- and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile WYETH LLC (US) 2010-01-19 US claimed
US-20080214507-A1 MONO-AND-DI-PHOSPHATES OF 3-(3-FLUORO-4-HYDROXY-PHENYL)-7-HYDROXY-NAPHTHALENE-1-CARBONITRILE WYETH (US) 2008-09-04 US claimed
EP-1361872-A4 NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS UNIV VIRGINIA (US) 2004-05-19 EP claimed
EP-1361872-A2 NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-11-19 EP claimed
WO-2002029001-A2 NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS UNIVERSITY OF VIRGINIAN PATENT FOUNDATION (US) 2002-04-11 WO claimed